
    
      Primary Objective:

      To compare the activity of the 2 regimens The primary end point will be the clinical complete
      response rate of each treatment arm among all registered cases (intent to treat analysis).

      Secondary Objectives:

      To compare the 2 treatment arms with respect to:

        -  Toxicity

        -  Progression Free Survival

        -  Overall survival

      Ancillary studies To evaluate before and after treatment a number of markers of hypoxia,
      neoangiogenesis, apoptosis, EGFR activating pathways.
    
  